FDA warns Curaleaf to stop marketing CBD with unfounded claims

FDA warns Curaleaf to stop marketing CBD with unfounded claims
July 23, 2019 Erik Ysea
In News Articles

CMW Media client EcoGen Labratories‘ Chief Growth Officer, Derek DuChesne, was featured in an article on The Boston Globe that discussed the FDA’s active role in the growing CBD industry.

“Many CBD companies say they welcome regulations to separate the bad actors from the good. The warning “just shows that the FDA is listening and is not turning a blind eye to what is going on or being said,” said Derek DuChesne, chief growth officer at EcoGen Laboratories, a CBD manufacturer.”

Read the FULL ARTICLE HERE

Comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *

*